The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting

被引：22
|
作者：
Bagul, Nitin Babulal [1 ]
Kirkham, Jamie J. [2 ]
机构：
[1] Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England
[2] Univ Liverpool, Dept Biostat, Liverpool L69 3GS, Merseyside, England
来源：
CLINICAL AND EXPERIMENTAL HYPERTENSION | 2012年 / 34卷 / 08期
关键词：
harm; adverse event; CONSORT; CONSORT extension; drug safety; ADVERSE EVENTS; QUALITY; STATEMENT; IMPROVE;
D O I：
10.3109/10641963.2012.681724
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The aim of this study was to assess the quality of reporting of harms in hypertension clinical trials identified from the Cochrane Database using the Consolidated Standards of Reporting Trials (CONSORT) extension for harms reporting. Forty-one hypertension trials were included in the study. On average trials reported less than half of the items recommended by the CONSORT extension for harms (mean 9.83 items; 95% confidence interval 8.06, 11.60). Trialists need to address the perceived shortcomings in measurement, analysis, and reporting of harms data so that the available trial data can be considered as a balanced and reliable source of evidence.
引用
收藏
页码：548 / 554
页数：7
相关论文
共 50 条
  • [1] Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms
    Shukralla, Arif A.
    Tudur-Smith, Catrin
    Powell, Graham A.
    Williamson, Paula R.
    Marson, Anthony G.
    EPILEPSY RESEARCH, 2011, 97 (1-2) : 20 - 29
  • [2] Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review
    Yuniar, Cindra Tri
    Pratiwi, Bhekti
    Ihsan, Ardika Fajrul
    Laksono, Bambang Tri
    Risfayanti, Iffa
    Fathadina, Annisa
    Jeong, Yeonseon
    Kim, Eunyoung
    VACCINES, 2022, 10 (02)
  • [3] Reporting of Complications in Rhinoplasty Randomized Controlled Trials: An Analysis Using the CONSORT Extension for Harms Checklist
    Hemmerich, Christian
    Corcoran, Adam
    Johnson, Austin L.
    Wilson, Andrew
    Orris, Olivia
    Arellanes, Russell
    Vassar, Matt
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 171 (01) : 81 - 89
  • [4] Better reporting of harms in randomized trials: An extension of the CONSORT statement
    Ioannidis, JPA
    Evans, SJW
    Gotzsche, PC
    O'Neill, RT
    Altman, DG
    Schulz, K
    Moher, D
    ANNALS OF INTERNAL MEDICINE, 2004, 141 (10) : 781 - 788
  • [5] Reporting of Harms by Randomized Controlled Trials in Ophthalmology
    O'Day, Roderick
    Walton, Richard
    Blennerhassett, Richard
    Gillies, Mark C.
    Barthelmes, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [6] CONSORT recommendations for reporting harms in clinical trials
    Reactions Weekly, 2004, 1031 (1) : 4 - 4
  • [7] Reporting of randomized controlled trials as per CONSORT guidelines
    Misra, Puneet
    Jha, Shreya
    Misra, Anoop
    Kant, Shashi
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (10) : 6598 - 6598
  • [8] Reporting randomized controlled trials in gastroenterology: The CONSORT statement
    Sandler, RS
    GASTROENTEROLOGY, 2001, 121 (04) : 755 - 755
  • [9] Enhanced reporting of randomized, controlled trials: The CONSORT statement
    Church, J
    DISEASES OF THE COLON & RECTUM, 2006, 49 (02) : 163 - 163
  • [10] Evaluating the quality of reporting occupational therapy randomized controlled trials by expanding the CONSORT criteria
    Moberg-Mogren, E
    Nelson, DL
    AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 2006, 60 (02): : 226 - 235
12345